Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK
Top Cited Papers
- 1 March 2015
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 148 (3), 603-615.e14
- https://doi.org/10.1053/j.gastro.2014.11.045
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- MerTK inhibition in tumor leukocytes decreases tumor growth and metastasisJCI Insight, 2013
- A Spatially-Organized Multicellular Innate Immune Response in Lymph Nodes Limits Systemic Pathogen SpreadCell, 2012
- Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic ratsGut, 2008
- Immunobiology of the TAM receptorsNature Reviews Immunology, 2008
- Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsisCritical Care, 2008
- TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune ResponseCell, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysisJournal of Hepatology, 2005
- Paralysed monocytes in acute on chronic liver diseaseJournal of Hepatology, 2005
- Expression profiling of IL‐10‐regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL‐10 therapyEuropean Journal of Immunology, 2004